1. How Pharma is targeting checkpoint inhibitors

    Interviewee/Contributer: Bruno Pagliara

    Organisation: 

    Read more

  2. Progress towards personalised cancer vaccines

    Interviewee/Contributer: Cornelis Melief

    Organisation: ISA Pharmaceuticals BV

    Read more

  3. Update on the new EU Clinical Trials Regulation

    Interviewee/Contributer: Rosie Bannister

    Organisation: MedNous

    Read more

  4. New body for regenerative medicine launched

    Interviewee/Contributer: Alexa Machikas and Elena Kfoury

    Organisation: Standards Coordinating Body

    Read more

  5. Seismic shift ahead for drug pricing

    Interviewee/Contributer: Victoria English

    Organisation: MedNous

    Read more

  6. Drugs for orphan diseases are no longer rare

    Interviewee/Contributer: Robin Davison

    Organisation: New Science Global Healthcare Fund

    Read more

  7. Why patient-reported outcomes matter

    Interviewee/Contributer: Andy Smith

    Organisation: ICON Commercialisation and Outcomes

    Read more

  8. Is an EU approval better than a hospital exemption?

    Interviewee/Contributer: Tim Farries

    Organisation: ERA Consulting Ltd

    Read more

  9. Q1 2017 stock market report: Biotechs climb to the top of the tree

    Interviewee/Contributer: William Ellington

    Organisation: MedNous

    Read more

  10. MedNous Briefing - The European Medicine Agency's PRIME Scheme

    Interviewee/Contributer: Clementine Brooks and Amy Ellington

    Organisation: MedNous

    Read more